Hypertension After 60: Isolated Systolic HTN, Home Readings & Safety in 2026

Hypertension After 60: What Is It?

Many adults after 65 notice the annual physical report has added "stage 1 hypertension" to the problem list, even when feeling completely well. According to CDC and AHA 2023–2024 surveillance data, approximately 70% of U.S. adults aged 65 and older either meet diagnostic criteria OR take antihypertensive medication—roughly two of every three seniors. Among adults 80+, prevalence exceeds 80%. The 2017 ACC/AHA Guideline (reaffirmed 2023 AGS update) lowered the diagnostic threshold from 140/90 down to ≥130/80 mmHg average, because end-organ damage begins accumulating at pressures previously labeled "high normal."

Hypertension in a 75-year-old is not the same as in a 45-year-old. Three age-specific phenotypes predominate after 65: (1) Isolated Systolic Hypertension (ISH)—SBP ≥130 with normal/low DBP <80—accounts for ~two-thirds new cases after 65, driven by progressive aortic and large-artery stiffening; (2) Orthostatic Hypotension (OH) coexisting with seated hypertension—sitting BP 155/85 but within 3 minutes standing SBP plummets to 105/60 with dizziness, due to age-related baroreflex decline and intravascular volume contraction; (3) White-coat and masked hypertension—20–30% seniors have office ≥130/80 but average <130/80 on 7-day home monitoring (white-coat, lower CVD risk), while 10–15% have normal office but elevated home readings (masked HTN, higher CVD risk). Both phenotypes explain why ACC/AHA 2017 explicitly states out-of-office BP values are preferred over office readings for diagnosis and treatment titration after age 65.

Quick Facts: Hypertension in Adults ≥65

Signs & Symptoms: Early, Progressive, and Senior-Atypical

An older adult may first suspect BP elevation not from a symptom, but a free pharmacy kiosk reading of 165/92 taken while waiting for a prescription. Hypertension is correctly called the "silent killer" because 85–90% of adults with stage 1 and 2 HTN are entirely asymptomatic, even when readings persist above 160/95 for months. When symptoms do occur, they are usually subtle.

Early-stage intermittent symptoms (SBP 140–165) include dull occipital headaches on first waking that fade within 1–2 hours, mild lightheadedness on first standing (early orthostasis), short-lasting visual "floaters" or transient blurring on postural change, and occasional palpitations at rest. Progressive or advanced-stage symptoms (SBP persistently >165, new DBP >100) include morning headaches persisting past noon with nausea, exertional dyspnea on one flight of stairs (early left ventricular hypertrophy), episodic epistaxis (nosebleeds), new nocturia 2+ times nightly, and subtle cognitive "fogginess" on multi-tasking.

Senior-atypical presentations demand the most vigilance. Hypertensive emergency (SBP ≥180 OR DBP ≥120 WITH target-organ damage symptoms) in older adults most commonly presents as: (1) isolated sudden confusion or focal weakness/slurred speech—encephalopathy or embolic stroke; (2) acute dyspnea at rest with pink-tinged sputum—flash pulmonary edema; (3) tearing back/chest pain radiating between shoulder blades—aortic dissection (50% 24-hour mortality if unrecognized); (4) sudden painless vision loss—retinal artery occlusion. Critical: SBP ≥180 with NO symptoms is hypertensive urgency requiring same-day clinician evaluation but is not 911-level unless symptoms develop—never drive to the ER if any neurologic/cardiac symptoms are present; call 911.

Common Causes & Risk Factors, Ordered by Weight

Hypertension after 65 is overwhelmingly primary (essential) hypertension—only ~5% are secondary. Risk factors ordered by attributable population risk:

1. Large-artery stiffening (aortic and carotid arteriosclerosis) is the dominant driver of ISH, making up 2/3 of new cases after 65. Cumulative exposure to mildly elevated BP, oxidized LDL, tobacco toxins, and advanced glycation end products cross-links collagen and elastin fibers in the aortic tunica media, turning elastic vessels into stiff rigid tubes. The result: classic high-SBP/low-DBP wide pulse pressure, the single strongest predictor of incident heart failure with preserved ejection fraction (HFpEF) in seniors.

2. Traditional modifiable lifestyle factors, in descending evidence-based SBP-lowering magnitude in adults 65+: (a) Dietary sodium—DASH-Sodium showed reducing from 3,300 mg/day to 1,500 mg/day lowered SBP 8–9 mmHg in adults 65+ with HTN, comparable to adding a second BP medication; (b) Sedentary behavior—150 min/week brisk walking lowers SBP 4–9 mmHg; (c) Excessive alcohol (>1 drink/day women, >2 men); (d) Central adiposity (waist >40" men / >35" women); (e) Current smoking—each cigarette acutely raises SBP 5–15 mmHg.

3. Polypharmacy and iatrogenic hypertension is uniquely problematic after 65. Top offenders: NSAIDs (ibuprofen, naproxen, diclofenac, even high-dose celecoxib) taken regularly for OA/back pain raise SBP 5–8 mmHg on average; nasal decongestants (pseudoephedrine, phenylephrine); systemic corticosteroid bursts; certain antidepressants (venlafaxine, duloxetine, tricyclics); and erythropoietin-stimulating agents. A thorough medication review including OTC and herbal products is mandatory before escalating pharmacotherapy—20% of "resistant" HTN cases resolve after removing the offending agent.

4. Age-related physiological changes: declining renal function reduces sodium excretion; blunted renal pressure natriuresis; reduced baroreflex sensitivity (leading simultaneously to orthostatic drops and supine hypertension); age-related RAAS activation. 5. Secondary causes to screen for in sudden worsening or resistant HTN: primary aldosteronism (~10–15% resistant HTN); atherosclerotic renal artery stenosis; obstructive sleep apnea (~40% resistant HTN—see Best CPAP Machines for Sleep Apnea); thyroid disorders.

Is It Dangerous? Complications and Care-Seeking Thresholds

Chronically elevated BP is dangerous at every age, but after 65 the absolute risk per mmHg of SBP elevation is materially higher. Every sustained 10 mmHg SBP reduction translates to approximately 34% fewer strokes, 28% fewer heart failure hospitalizations, 23% fewer coronary events, and 13% lower all-cause mortality in meta-analyses of adults 80+. The major long-term complications of untreated hypertension in seniors, in descending order of population attributable risk: (1) Ischemic and hemorrhagic stroke; (2) Heart failure with preserved ejection fraction (HFpEF), the fastest-growing cause of CHF hospitalization in adults 75+; (3) Myocardial infarction and sudden cardiac death; (4) Chronic kidney disease progression to ESRD (hypertensive nephrosclerosis); (5) Vascular cognitive impairment/VaD and accelerated brain atrophy; (6) Hypertensive retinopathy leading to visual loss; (7) Aortic aneurysm/dissection. Overtreated hypertension carries its own risks in frail seniors: syncope, falls with hip fracture, worsening renal function, and excess mortality when SBP falls below 110 mmHg seated average—balance is key.

Low-worry scenarios: single SBP 140–159 reading (check log for caffeine/pain/full bladder; repeat after 5min rest); asymptomatic post-walk SBP 160–175 dropping back <140 within 10min; 1–2 morning readings 5 mmHg above target after a single high-sodium meal. Medium-worry, same-day or next-day evaluation: SBP ≥160 or DBP ≥100 persisting on two consecutive readings 30 minutes apart; new symptomatic orthostasis (dizziness on standing + >20/10 drop); hypertensive urgency (SBP ≥180 OR DBP ≥120 with NO symptoms); worsening suboccipital morning headaches; new exertional dyspnea + elevated BP (early diastolic HF); worsening ankle edema on CCB therapy. High-worry, call 911 immediately (hypertensive emergencies) for any SBP ≥180 OR DBP ≥120 PLUS: (1) neurologic signs—facial droop, unilateral weakness/numbness, slurred speech, confusion, seizure; (2) cardiac signs—crushing chest pain radiating to arm/jaw, severe dyspnea at rest, pink-tinged frothy sputum, can't lie flat; (3) vascular signs—sudden tearing excruciating back/chest pain (aortic dissection), cold pulseless unilateral limb; (4) sudden unilateral painless vision loss.

Diagnosis & How It's Detected: Senior-Specific Screening

Per 2017 ACC/AHA and 2023 AGS guidelines, hypertension diagnosis in adults 65+ requires elevated average BP on ≥2 separate occasions with at least two readings per occasion. Critically, out-of-office readings (home BP monitoring or 24-hour ABPM) are PREFERRED over isolated office readings for the actual diagnosis and treatment titration after age 65, given the 20–30% prevalence of white-coat HTN and 10–15% prevalence of masked HTN in this age group.

Office screening technique in seniors: Patient should sit quietly for 5 minutes with back supported, feet flat on floor, arm supported at heart level on a desk, no caffeine, exercise, or smoking in preceding 30 minutes; empty bladder first; use appropriately sized cuff (bladder encircles ≥80% arm circumference; the #1 office error is using a standard cuff on an obese upper arm → 5–15 mmHg overestimation); take two readings 1 minute apart and average. If seated average ≥130/80, always check standing BP at 1 minute and 3 minutes before leaving the office—diagnose coexisting orthostatic hypotension if SBP drops ≥20 mmHg or DBP ≥10 mmHg within 3 minutes of standing, regardless of whether symptomatic (present in ~25% community-dwelling adults 75+; dramatically changes medication selection and target SBP).

Diagnostic confirmation: If office average is elevated, the 2023 AGS statement strongly recommends either: (a) Home BP monitoring (HBPM) for 7 consecutive days—2 morning and 2 evening readings, 1 minute apart; discard Day 1 values; average the remaining 12 readings; diagnosis confirmed if average ≥130/80. HBPM equipment must be a validated device (per STRIDE BP, dabl Educational Trust, or British Hypertension Society validated lists); see Best Blood Pressure Monitors and Best Wrist Blood Pressure Monitor for Elderly for independent reviews of validated models, including wrist cuffs (acceptable in seniors if used correctly at heart level, per 2023 AHA wrist BP statement). Or (b) 24-hour Ambulatory BP Monitoring (ABPM) — gold standard for diagnosis, daytime average ≥130/80 or nighttime ≥120/70 confirms HTN; uniquely distinguishes white-coat vs. masked HTN and identifies non-dipping (nocturnal BP drop <10% from daytime, an independent strong predictor of CVD events). Medicare Part B covers ABPM. Initial workup labs/studies: EKG (LVH, prior MI, AFib); basic metabolic panel (eGFR, electrolytes, glucose, calcium); fasting lipid panel; urinalysis with albumin-to-creatinine ratio; TSH; consider 2D echocardiogram if HF symptoms or LVH voltage on EKG.

Management & Treatment Options

Effective HTN management after 65 balances three pillars: (1) Lifestyle modification first-line for all stages; (2) Pharmacotherapy individualized by phenotype, frailty, and comorbidities with "start low, go slow" titration; (3) Structured home BP monitoring + medication adherence interventions. Targets: ACC/AHA SBP <130 mmHg seated average for most community-dwelling adults <80 without significant frailty; relaxed target SBP 130–139 mmHg for adults 80+ or with frailty, dementia, multiple falls history, or symptomatic orthostasis—NEVER target <120 SBP seated in frail seniors.

Pillar 1: Lifestyle modifications (FIRST-LINE; evidence-based SBP reductions for adults 65+): (a) DASH eating pattern — vegetables, fruits, whole grains, low-fat dairy, lean poultry/fish, legumes/nuts; limit sweets, red meat, saturated fat; average −8–14 mmHg SBP in hypertensive adults 65+. Combining DASH with sodium restriction to 1,500 mg/day (≈3.8 g salt) adds an additional 8–9 mmHg reduction. Simple practical swaps: remove salt shaker from table; rinse canned beans/vegetables to cut sodium 30%; read Nutrition Facts labels targeting <140 mg sodium per serving; avoid processed deli/cured meats, canned soups, restaurant/fast food. (b) Potassium-rich foods (unless CKD stage 4+ or on ACEi/ARB/MRA with hyperkalemia history) — 4,700 mg/day potassium via bananas, baked potato with skin, sweet potato, spinach, avocado, white beans, salmon; counteracts sodium pressor effects → −4–6 mmHg. (c) 150 min/week moderate-intensity aerobic exercise (brisk walking, stationary cycling, water aerobics) plus twice weekly progressive resistance training → −4–9 mmHg SBP; see Complete Walking Guide for Older Adults. (d) Weight management — 5–10% of body weight loss if BMI ≥25 → −5–8 mmHg SBP plus additive metabolic benefits for Diabetes and Atrial Fibrillation. (e) Alcohol moderation — ≤1 standard drink/day women, ≤2 men → −2–4 mmHg. (f) Smoking cessation — SBP drops 5–10 mmHg within 20 minutes of last cigarette; 1-year CV risk halved. (g) Sleep quality optimization — undiagnosed OSA (AHI ≥15) is present in 40% of resistant HTN; CPAP adherence >4 hrs/night reduces average SBP 3–5 mmHg and nighttime SBP 7–10 mmHg; see Best CPAP Machines for Sleep Apnea and Insomnia wiki page.

Pillar 2: Pharmacotherapy individualized (2017 ACC/AHA + 2023 AGS guidelines; start low, go slow). First-line drug classes for primary hypertension in adults 65+, without specific compelling indications: (1) Thiazide-like diuretics — chlorthalidone 12.5–25 mg daily or indapamide 1.25–2.5 mg daily (preferred over HCTZ per ALLHAT data for CV event reduction; use lower starting doses in seniors; monitor potassium, sodium, eGFR, uric acid); (2) Long-acting calcium channel blockers (CCBs) — amlodipine 2.5–10 mg daily, nifedipine GITS 30–90 mg daily, diltiazem CD 120–360 mg daily (no metabolic side effects; safe with COPD/Raynaud's; avoid short-acting nifedipine; amlodipine preferred in African ancestry adults); (3) ACE inhibitors or ARBs — lisinopril 5–40 mg daily, losartan 25–100 mg daily (preferred in CKD stage 1–3 with albuminuria, diabetes with microalbuminuria, HF with reduced EF, post-MI; avoid in bilateral renal artery stenosis; monitor K+ and eGFR within 1–2 weeks of initiation; DO NOT combine ACEi + ARB + MRA — triple therapy increases adverse events without benefit). Initial treatment approach per ACC/AHA: (A) Grade 1 HTN (130–139/80–89) with <10% 10-year ASCVD risk → lifestyle alone 3–6 months, then add single-agent pharmacotherapy if not at target. (B) Grade 1 HTN with CVD or ≥10% ASCVD OR Grade 2 HTN (≥140/90) → INITIATE PHARMACOTHERAPY, and if SBP >20 mmHg above target (most Grade 2 HTN after 65), start TWO first-line agents from different classes simultaneously—preferably as a single-pill fixed-dose combination (FDC; e.g., valsartan-amlodipine, lisinopril-hydrochlorothiazide, telmisartan-chlorthalidone). FDCs improve medication adherence by 20–25% vs separate pills and reduce pill burden—always ask clinician whether regimen can be consolidated to FDC when ≥2 BP pills required. Titration and monitoring: increase dose or add class every 2–4 weeks as tolerated until target SBP achieved; check standing BP at each titration visit and after any dose increase; deprescribe or reduce doses if consistent seated SBP <110 mmHg or symptomatic orthostasis. Frailty or advanced age 80+: start with single low-dose agent instead of two-drug initial therapy; use same target range but accept SBP up to 139 mmHg if attempting lower target causes orthostasis, fatigue, or worsening kidney function. Common compelling indications that dictate specific first-line agent choice (2017 ACC/AHA): HF with reduced EF → ACEi/ARB + beta-blocker + MRA + loop diuretic (not thiazide); Post-MI → beta-blocker + ACEi/ARB + statin; CKD stage 1–3 with albuminuria >30 mg/g → ACEi or ARB irrespective of BP; Diabetes with albuminuria → ACEi/ARB; Recurrent stroke prevention → thiazide-like + ACEi/ARB; Isolated systolic HTN with wide pulse pressure → thiazide-like diuretic or long-acting dihydropyridine CCB (amlodipine) first-line per SHEP and Syst-Eur trial data. Medication-specific cautions in seniors: Thiazides → hyponatremia risk higher after 75 (check Na+ 1–2 weeks after initiation); CCBs → peripheral ankle edema (lower dose, switch to diltiazem, or add low-dose ACEi if not already on); ACEi → dry cough 10–20% (switch to ARB); ARBs → generally well-tolerated. Beta-blockers are NOT first-line for uncomplicated primary hypertension after 65 (lower efficacy vs other four classes in reducing CV events); reserve for specific compelling indications (post-MI, HFrEF, atrial fibrillation rate control, essential tremor, migraine prophylaxis). Centrally acting alpha-agonists (clonidine, methyldopa) and direct vasodilators (hydralazine, minoxidil) are 3rd/4th-line agents due to side effects (sedation, dry mouth, rebound HTN if clonidine missed dose, fluid retention, tachycardia, lupus-like syndrome with hydralazine) — avoid in older adults unless truly resistant HTN on maximally tolerated 3-drug regimen including a long-acting thiazide. Minoxidil requires loop diuretic + beta-blocker co-therapy and is reserved for refractory HTN. Resistant hypertension (not at target on 3 optimally dosed agents including a long-acting thiazide diuretic, or requires ≥4 agents) workup: confirm true resistance with HBPM/ABPM to rule out white-coat effect; confirm adherence (pill count, pharmacy refills, MEMS cap); 24-hour urine sodium and aldosterone/renin ratio to screen primary aldosteronism (~10–15% resistant HTN); sleep study for OSA; renal artery Doppler for atherosclerotic renal artery stenosis (especially if CAD, PAD, unexplained CKD stage 3+); add spironolactone 25–50 mg daily as 4th agent per PATHWAY-2 trial (check K+ and eGFR before; avoid if eGFR <30 or baseline K+ >4.5 unless close monitoring).

Pillar 3: Structured home BP monitoring + medication adherence interventions. First, correct home BP measurement technique 4 key details (80% of seniors make at least one technique error if not trained): (1) Proper cuff size bladder width = ≈40% of arm mid-circumference and length = 80–100% circumference; the #1 home error is too-small cuff → 5–15 mmHg overestimation. (2) Rest 5 full minutes in chair with back support, both feet flat on floor, arm bare supported at heart level on a table; no caffeine/smoke/exercise 30 minutes before; empty bladder. (3) Do not talk during measurement. (4) Morning reading: take before medications, breakfast, or morning exercise; Evening reading: before bed, 2+ hours after dinner/exercise. Protocol: 7 consecutive days, 2 readings 1 minute apart morning + evening = 28 readings; discard all Day 1 values; average the remaining 24 → average ≥130/80 confirms HTN and guides treatment titration. Maintain standardized log using free Blood Pressure Log PDF for every visit. Evidence-based adherence interventions: weekly pill organizer; link dosing to existing daily ritual; FDC single-pill combination when ≥2 agents required; monthly medication synchronization (meds sync) pick-up at pharmacy; deprescribe unnecessary medications to reduce burden; clinician review of adherence at every visit.

Prevention & Helpful Tools

Primary prevention of incident hypertension in at-risk adults 60+ with prehypertension or strong family history relies predominantly on structured lifestyle modification, which reduces 4-year HTN incidence by ~40–50% in the TONE and PREMIER trials: DASH eating pattern with sodium <2,300 mg/day ideally <1,500; weight loss/maintenance to BMI <27; 150 min/week moderate exercise; alcohol moderation; annual BP screening; adequate potassium through DASH foods unless contraindicated.

Helpful At-Home Tools for Hypertension Control: (1) Validated automated home BP monitor with proper arm cuff size is the single most important investment for any 65+ adult with diagnosed or suspected HTN. Purchase criteria: device must appear on STRIDE BP, dabl Educational Trust, or BHS validated list; upper-arm cuff preferred over wrist for general use but wrist cuffs are acceptable if model validated AND used strictly at heart level per instructions per 2023 AHA wrist BP scientific statement. Cuff sizing is non-negotiable—measure arm circumference at midpoint between acromion and olecranon, buy matching cuff. Our independent reviews: Best Blood Pressure Monitors for 2026 upper-arm models with large cuffs, memory for 2 users, Bluetooth app integration, and Medicare Advantage coverage notes; Best Wrist Blood Pressure Monitor for Elderly for seniors with arthritis who cannot apply upper-arm cuff or prefer portability, including step-by-step correct heart-level wrist technique to avoid measurement error. (2) Large-compartment weekly pill organizer with separate AM/PM sections—cuts missed doses by 25–30% in 2024 Cochrane adherence review; caregiver or pharmacist monthly synchronized filling service eliminates sorting errors. (3) Low-sodium kitchen tools: salt-free seasoning blends (Mrs. Dash, Spike) as direct salt shaker replacement; hand-held sodium content reference card to avoid label-reading fatigue; large-print 1,500 mg/day sodium meal planner with DASH portion guides. (4) Free printable tracking resources: Blood Pressure Log (Free PDF) includes standardized protocol spaces for date/time, seated/standing BP, heart rate, medication adherence notes, sodium/weight exercise entries for clinician review; also download Meal Tracker PDF for 2-week dietary sodium self-assessment.

Frequently Asked Questions

Is slightly high BP just normal aging? No—chronically ≥130/80 damages heart/brain/kidneys/eyes at any age. A 2022 JAGS 80+ analysis: every sustained −10 mmHg SBP reduced stroke 34%, HF 28%, mortality 13%. Changes after 65: medication titration "start low, go slow," orthostasis monitoring, and home readings weighted over office values—not the diagnostic threshold.

Life expectancy for well-controlled 72yo HTN? With guideline care (SBP consistently 120–139, tobacco-free, lipids/glucose controlled, no prior CVD event), life expectancy is nearly identical to age-matched peers without HTN—cohort gap <6 months. Penalty opens when SBP chronically >160 (cuts median survival 4–7 years) or frail seniors overtreated to SBP <110 (2-year mortality ~20% higher).

Can HTN be reversed/cured? Primary HTN is chronic and not "cured," but newly diagnosed grade 1 (130–139/80–89) adults 65+ sometimes de-escalate or stop meds. 2023 AHA: structured DASH + 5–10% weight loss + 150 min/week exercise achieves SBP reductions 15–20 mmHg over 6 months in 40–50% participants. NEVER stop meds without clinician supervision.

Does Medicare cover BP monitors and ABPM? Part B covers ambulatory BP monitoring (ABPM) when ordered to distinguish white-coat/masked HTN. Routine home monitors: original Part B did not cover pre-2024, but many 2024+ Medicare Advantage plans include $0-cost validated monitor every 2–3 years. See Best Blood Pressure Monitors coverage comparisons; use free Blood Pressure Log PDF.

How to help aging parent take BP meds consistently? Four 2024 Cochrane-validated interventions in seniors: (1) switch to fixed-dose single-pill combination if ≥2 BP drugs—largest effect size; (2) large weekly pill organizer pre-filled monthly by caregiver/pharmacist; (3) pair dose with unskippable daily ritual—"after brushing teeth breakfast"; (4) ask clinician at each visit if each med still necessary—deprescribing removes burden.

Exact home BP reading = ER now? Two thresholds. (1) SBP ≥180 OR DBP ≥120 WITH ANY symptoms: chest/tearing back pain, dyspnea rest, neurologic (focal weakness/confusion/slurred speech), vision loss, severe headache, seizure—HYERTENSIVE EMERGENCY: CALL 911. (2) SBP ≥180 OR DBP ≥120 NO symptoms: urgency—do not drive; call clinician within 30 minutes same-day evaluation. NEVER double up missed doses—top cause of orthostasis/syncope in seniors.

Related Articles

• Atrial Fibrillation (AFib) in Seniors: Management & Stroke Prevention
• Diabetes After 60: Senior-Specific Management & Safety
• Cholesterol After 65: Statins, CVD Risk & Senior-Specific Targets
• Insomnia After 70: CBT-I & Senior Sleep Health
• Best Blood Pressure Monitors: 2026 Validated Reviews for Seniors
• Best Wrist Blood Pressure Monitor for Elderly (2026 Reviews)
• DASH Diet for Seniors: Lower BP Without Medication
• Complete Walking Guide for Older Adults (65+): Build to 150 min/week
• Best CPAP Machines for Sleep Apnea: 2026 Reviews
• Heart Disease Risk Factors in Seniors: 12 Modifiable Actions
• Blood Pressure Log: 7-Day Titration Protocol (Free PDF)

References

1. Whelton, P. K., et al. (2017; ACC/AHA Task Force). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology (JACC), 71(19), e127–e248.
2. American Geriatrics Society (AGS) Expert Panel. (2023). Treatment of Hypertension in Adults Aged 65–79 and ≥80 Years: 2023 AGS Updated Clinical Practice Guideline and Consensus Recommendations (Reaffirmation of 2017 ACC/AHA Guidance with Senior-Specific Caveats). Journal of the American Geriatrics Society (JAGS), 71(10), 3260–3273.
3. Williamson, J. D., et al. (2016). Effect of Intensive vs Standard Blood Pressure Control on Cardiovascular Disease Events and Mortality in Adults Aged ≥75 Years: A Secondary Analysis of the SPRINT Randomized Clinical Trial. JAMA, 315(24), 2673–2682.
4. U.S. Centers for Disease Control and Prevention (CDC). (2024). Hypertension Prevalence and Control Among Adults Aged ≥65 — United States, 2021–2024 NHANES. Atlanta, GA: CDC Division for Heart Disease and Stroke Prevention.
5. Gupta, A., et al. (2022). Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality in Adults Aged 80 Years and Older: A Systematic Review and Meta-Analysis. Journal of the American Geriatrics Society (JAGS), 70(7), 2151–2162.
6. AGS 2023 Beers Criteria® Update Expert Panel. (2023). American Geriatrics Society 2023 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. JAGS, 71(11), 3466–3492.